Our operating leases primarily consist of offices and lab space, machinery, equipment, and vehicles. We terminated certain leases in the U.S. and other international locations during the six months ending June 30, 2026 and 2025. See Note 12 - Other (Income) Expense, net for additional information regarding lease termination costs.

The components of lease expense and other information are as follows (in thousands):


	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2026			2025			2026			2025
Consolidated Statements of Operations:
Operating lease expense	$	4,294		$	4,168		$	8,769		$	8,346
Short-term lease expense		470			392			881			881
Variable lease expense		481			378			960			859
Total lease expense	$	5,245		$	4,938		$	10,610		$	10,086
Consolidated Statements of Cash Flows:
Operating cash flows - operating leases payments	$	5,184		$	4,689		$	9,615		$	8,895
Right of use assets obtained in exchange for operating lease liabilities	$	1,725		$	721		$	6,079		$	4,876
Other information:
Weighted-average remaining lease term - operating leases	7.73 years			8.36 years			7.73 years			8.36 years
Weighted-average discount rate - operating leases		5.46	%		5.47	%		5.46	%		5.47	%

Scheduled undiscounted lease payments for non-cancellable operating leases consist of the following (in thousands):


	June 30, 2026
	Operating Leases
Remainder of 2026	$	7,456
2027		12,643
2028		9,959
2029		6,501
2030		4,571
Thereafter		22,922
Total undiscounted lease payments		64,052
Less: Imputed interest		(12,798	)
Total operating lease liabilities	$	51,254